Long-Term Study of Metformin Added to Diet and Lifestyle in Pregnant Women with Gestational Diabetes to Improve Outcomes for Mother and Child
Led by Bethesda Diabetes Research Center · Updated on 2022-02-10
500
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Gestational diabetes mellitus GDM is a growing concern worldwide, affecting 5-10% of pregnancies and leading to risks during pregnancy, delivery, and long-term health problems such as type 2 diabetes and obesity for both mother and child. This research aims to evaluate whether metformin, given early from the time of GDM diagnosis alongside diet and lifestyle changes, improves important pregnancy outcomes over many years. The study is a randomized controlled trial called the POEM study, designed to fill the gap in research on early metformin use in GDM treatment.
The trial involves three phases Phase A lasts from the start of the study until six weeks after delivery, comparing two groupsone receiving diet, lifestyle advice, and metformin, and the other receiving diet and lifestyle advice alone, with insulin rescue if needed. Phase B continues from six weeks to one year after delivery, focusing on the mothers ongoing treatment with or without metformin. Phase C is an observational follow-up from one to 20 years after delivery, monitoring mother and child without study medication. Metformin dosing ranges from 850 mg once to three times daily, adjusted based on tolerance.
Participants will have regular assessments including blood glucose tests, pregnancy outcome measures summarized by a new GDM Outcome Score, and long-term monitoring of type 2 diabetes and obesity in mother and child. Researchers will collect data through clinical visits, laboratory tests, and questionnaires over up to 20 years. Safety and compliance will be monitored throughout, and the study aims to provide meaningful insights into managing GDM and its effects over time.
CONDITIONS
Brief Title
Pregnancy Outcomes: Effects of Metformin Study (POEM Study)
Research Team
A
Adriaan Kooy, Dr
L
Louise Smit
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Pregnant women diagnosed with gestational diabetes mellitus based on fasting plasma glucose > 5.3 mMol and/or oral glucose tolerance test plasma glucose > 7.8 mMol two hours after 75 grams glucose intake
Written informed consent provided
Age between 18 and 45 years
Gestational age at inclusion between 16 and 32 weeks
Glycohemoglobin test (HbA1c) at inclusion of 48 mmol/mol (6.5%) or less
You will not qualify if you...
Diabetes mellitus before pregnancy, except previous gestational diabetes
Proteinuria with urine albumin-to-creatinine ratio > 35 mg/mmol at screening
Malignancy in the last 5 years except non-melanoma skin cancer
Psychiatric or mood disorder potentially affecting treatment compliance
Chronic liver disease or liver enzymes (ASAT/ALAT) more than 3 times the upper normal limit
Chronic renal failure with glomerular filtration rate below 45 ml/min/1.73m2
Chronic pulmonary failure with hypoxia
Uncontrolled hypertension with systolic blood pressure over 160 mm Hg despite treatment
Chronic corticosteroid treatment
Intolerance or earlier use of metformin during this pregnancy
Membership in the POEM study group
Severe fetal anomalies such as major neural tube or cardiac malformations at inclusion
Ruptured membranes
Multiple pregnancy
Inability to understand or read Dutch language
History of bariatric surgery
Hyperemesis gravidarum
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - From inclusion until six weeks after delivery
Participants receive metformin on top of diet and lifestyle counseling with insulin rescue if needed, or usual care with diet and lifestyle counseling and insulin rescue if needed, from the start of gestational diabetes diagnosis until six weeks after delivery.
Regular visits throughout pregnancy and up to six weeks postpartum
Treatment
Duration - Six weeks to 1 year after delivery
Participants continue receiving metformin on top of usual care or usual care alone from six weeks until 1 year after delivery.
Visits scheduled during the first year postpartum
Long-term Monitoring
Duration - 1 to 20 years after delivery
Participants and their children are observed without study medication to assess long-term outcomes up to 20 years after delivery.
Periodic follow-up visits during long-term observation
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing 1 Hour Versus 2 Hours Post-Meal Blood Sugar Monitoring in Pregnant Women with Gestational Diabetes on Treatment
Study Comparing Muscle and Nerve Function in Adults Aged 60 to 85 Who Are Regular Exercisers or Untrained
Randomized Trial Comparing Immediate Postpartum Diabetes Screening to Standard 4-12 Week Screening
and Follow-Up Study on Patient Perspectives to Improve Cardiovascular Health After Gestational Diabetes
Reducing Added Sugar Intake in BlackAfrican American and Latine Adolescents with Obesity by Replacing Sugary Sodas with Unsweetened or Reduced-Sugar Beverages
ActiveGirls Study Increasing Physical Activity to Support Hormone Health and Reduce Diabetes Risk in Girls Ages 8 to 12
Assessment of Pancreatic Beta-Cell Reserve Using Alpelisib Challenge Test and Hyperglycemic Clamp in Adults with Varying Body Weights
Physical Activity Options to Improve Blood Sugar Control in Postmenopausal Breast Cancer Survivors Using Hormone Therapy
Study of Serum Asprosin and Selected microRNAs as Diagnostic Markers in Young Women with Metabolic Syndrome
Brain Health and Metabolic Risk in Youth Ages 12 to 17 With Different Body Weights and Blood Sugar Levels
Study of Muscle Loss in Advanced Lung Cancer and How Exercise May Help
Investigating Molecular Causes and Effects on Patients and Caregivers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Pregnancy Outcomes: Effects of Metformin (POEM) study: a protocol for a long-term, multicentre, open-label, randomised controlled trial in gestational diabetes mellitus.
Eline G M van Hoorn, Peter R van Dijk, Jelmer R Prins...